Predicting Survival Within the Lung Cancer Histopathological Hierarchy Using a Multi-scale Genomic Model of Development

Overview

Journal PLoS Med

Specialty General Medicine

Date 2006 Jun 28

PMID 16800721

Citations 40

Authors

Hongye Liu

Alvin T Kho

Isaac S Kohane

Yao Sun

Affiliations

Soon will be listed here.

Abstract

Background: The histopathologic heterogeneity of lung cancer remains a significant confounding factor in its diagnosis and prognosis-spurring numerous recent efforts to find a molecular classification of the disease that has clinical relevance.

Methods And Findings: Molecular profiles of tumors from 186 patients representing four different lung cancer subtypes (and 17 normal lung tissue samples) were compared with a mouse lung development model using principal component analysis in both temporal and genomic domains. An algorithm for the classification of lung cancers using a multi-scale developmental framework was developed. Kaplan-Meier survival analysis was conducted for lung adenocarcinoma patient subgroups identified via their developmental association. We found multi-scale genomic similarities between four human lung cancer subtypes and the developing mouse lung that are prognostically meaningful. Significant association was observed between the localization of human lung cancer cases along the principal mouse lung development trajectory and the corresponding patient survival rate at three distinct levels of classical histopathologic resolution: among different lung cancer subtypes, among patients within the adenocarcinoma subtype, and within the stage I adenocarcinoma subclass. The earlier the genomic association between a human tumor profile and the mouse lung development sequence, the poorer the patient's prognosis. Furthermore, decomposing this principal lung development trajectory identified a gene set that was significantly enriched for pyrimidine metabolism and cell-adhesion functions specific to lung development and oncogenesis.

Conclusions: From a multi-scale disease modeling perspective, the molecular dynamics of murine lung development provide an effective framework that is not only data driven but also informed by the biology of development for elucidating the mechanisms of human lung cancer biology and its clinical outcome.

Citing Articles

A novel 5-differentially expressed gene (DEG) signature predicting the prognosis in patients with metastatic liver malignancies and the prognostic and therapeutic potential of SPP1.

Liu J, Yu Z, Liu Q, Dou C, Cao P, Xie X Int J Clin Oncol. 2025; .

PMID: 40014188 DOI: 10.1007/s10147-025-02723-3.

Identification of Prognostic Biomarkers for Multiple Solid Tumors Using a Human Villi Development Model.

Zhang B, Wang Y, Li H, Feng L, Li W, Cheng S Front Cell Dev Biol. 2020; 8:492.

PMID: 32656211 PMC: 7325693. DOI: 10.3389/fcell.2020.00492.

Dissecting expression profiles of gastric precancerous lesions and early gastric cancer to explore crucial molecules in intestinal-type gastric cancer tumorigenesis.

Zhang Y, Wu X, Zhang C, Wang J, Fei G, Di X J Pathol. 2020; 251(2):135-146.

PMID: 32207854 PMC: 7317417. DOI: 10.1002/path.5434.

Identification of prognostic genes in colorectal cancer through transcription profiling of multi-stage carcinogenesis.

An N, Zhao C, Yu Z, Yang X Oncol Lett. 2019; 17(1):432-441.

PMID: 30655784 PMC: 6313101. DOI: 10.3892/ol.2018.9632.

Genome-wide screening identifies oncofetal lncRNA Ptn-dt promoting the proliferation of hepatocellular carcinoma cells by regulating the Ptn receptor.

Huang J, Jiang H, Cai H, Liu Y, Zhu Y, Lin S Oncogene. 2019; 38(18):3428-3445.

PMID: 30643194 DOI: 10.1038/s41388-018-0643-z.

References

Paez J, Janne P, Lee J, Tracy S, Greulich H, Gabriel S . EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004; 304(5676):1497-500. DOI: 10.1126/science.1099314. View

Lynch T, Bell D, Sordella R, Gurubhagavatula S, Okimoto R, Brannigan B . Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004; 350(21):2129-39. DOI: 10.1056/NEJMoa040938. View

Takada M, Hirata K, Ajiki T, Suzuki Y, Kuroda Y . Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells. Hepatogastroenterology. 2004; 51(58):928-30. View

Mehta T, Tanik M, Allison D . Towards sound epistemological foundations of statistical methods for high-dimensional biology. Nat Genet. 2004; 36(9):943-7. DOI: 10.1038/ng1422. View

Sakamoto H, Zhang X, Suenobu S, Ohbo K, Ogawa M, Suda T . Cell adhesion to ephrinb2 is induced by EphB4 independently of its kinase activity. Biochem Biophys Res Commun. 2004; 321(3):681-7. DOI: 10.1016/j.bbrc.2004.07.016. View

Finzel A, Reininger A, Bode P, Wurzinger L . ICAM-1 supports adhesion of human small-cell lung carcinoma to endothelial cells. Clin Exp Metastasis. 2004; 21(3):185-9. DOI: 10.1023/b:clin.0000037696.36108.27. View

Tomoda T, Kurashige T, Moriki T, Yamamoto H, Fujimoto S, Taniguchi T . Enhanced expression of poly(ADP-ribose) synthetase gene in malignant lymphoma. Am J Hematol. 1991; 37(4):223-7. DOI: 10.1002/ajh.2830370402. View

McCue P, FINKEL G . Small-cell lung carcinoma: an evolving histopathological spectrum. Semin Oncol. 1993; 20(2):153-62. View

Nagpal S, Patel S, Jacobe H, DiSepio D, Ghosn C, Malhotra M . Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol. 1997; 109(1):91-5. DOI: 10.1111/1523-1747.ep12276660. View

10.

Eisen M, Spellman P, Brown P, Botstein D . Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998; 95(25):14863-8. PMC: 24541. DOI: 10.1073/pnas.95.25.14863. View

11.

Perl A, Whitsett J . Molecular mechanisms controlling lung morphogenesis. Clin Genet. 1999; 56(1):14-27. DOI: 10.1034/j.1399-0004.1999.560103.x. View

12.

Wheeler D, Barrett T, Benson D, Bryant S, Canese K, Church D . Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2004; 33(Database issue):D39-45. PMC: 540016. DOI: 10.1093/nar/gki062. View

13.

Pelosi G, Rodriguez J, Viale G, Rosai J . Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am J Surg Pathol. 2005; 29(2):179-87. DOI: 10.1097/01.pas.0000149690.75462.29. View

14.

Jemal A, Murray T, Ward E, Samuels A, Tiwari R, Ghafoor A . Cancer statistics, 2005. CA Cancer J Clin. 2005; 55(1):10-30. DOI: 10.3322/canjclin.55.1.10. View

15.

Bartling B, Hofmann H, Weigle B, Silber R, Simm A . Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis. 2004; 26(2):293-301. DOI: 10.1093/carcin/bgh333. View

16.

Fry W, Phillips J, Menck H . Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer. 1999; 86(9):1867-76. DOI: 10.1002/(sici)1097-0142(19991101)86:9<1867::aid-cncr31>3.0.co;2-9. View

17.

Alter O, Brown P, Botstein D . Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci U S A. 2000; 97(18):10101-6. PMC: 27718. DOI: 10.1073/pnas.97.18.10101. View

18.

Cardoso W . Lung morphogenesis revisited: old facts, current ideas. Dev Dyn. 2000; 219(2):121-30. DOI: 10.1002/1097-0177(2000)9999:9999<::aid-dvdy1053>3.3.co;2-8. View

19.

Wu T . Analysing gene expression data from DNA microarrays to identify candidate genes. J Pathol. 2001; 195(1):53-65. DOI: 10.1002/1096-9896(200109)195:1<53::AID-PATH891>3.0.CO;2-H. View

20.

Bhattacharjee A, Richards W, Staunton J, Li C, Monti S, Vasa P . Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A. 2001; 98(24):13790-5. PMC: 61120. DOI: 10.1073/pnas.191502998. View